HLA‐A2‐restricted CTL epitopes of a novel lung cancer‐associated cancer testis antigen, cell division cycle associated 1, can induce tumor‐reactive CTLMichiko Harao, Yasuharu Nishimura, Takuya Tsunoda et al.|International Journal of Cancer|2008Cited by 92
Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray AnalysisYoshihiro Yoshitake, Yasuharu Nishimura, Tetsuya Nakatsura et al.|Clinical Cancer Research|2004Cited by 67
A novel tumor‐associated antigen, cell division cycle 45‐like can induce cytotoxic T‐lymphocytes reactive to tumor cellsYusuke Tomita, Yasuharu Nishimura, Katsunori Imai et al.|Cancer Science|2011Cited by 46
The forkhead box M1 transcription factor as a candidate of target for anti‐cancer immunotherapyKazunori Yokomine, Yasuharu Nishimura, Satoru Senju et al.|International Journal of Cancer|2009Cited by 40
Identification of SPARC as a candidate target antigen for immunotherapy of various cancersMitsuhiro Inoue, Yasuharu Nishimura, Satoru Senju et al.|International Journal of Cancer|2010Cited by 39